Skip to main content
SpringerLink
Log in

Endoscopic Indices for Ulcerative Colitis

  • Chapter
  • First Online:
Advances in Endoscopy in Inflammatory Bowel Disease

  • 1394 Accesses

Abstract

Colonoscopy is a gold standard in assessing disease severity of ulcerative colitis, and therefore efforts have been made in order to quantify the severity of inflammation by endoscopic indices. Most indices have been proposed to assess the efficacy of clinical trials, and therefore not been validated. Baron score, ulcerative colitis endoscopic index of severity (UCEIS), and ulcerative colitis colonoscopic index of severity (UCCIS) are validated. There are some scoring systems in which different factors are graded for each item separately [Baron score, Rachmilewitz score, endoscopic activity index (EAI, UCEIS and UCCIS), and others grading multiple aspects altogether (Matts’ endoscopic grading, the Mayo endoscopic subscore (MES)]. It is essential to understand both strength and weakness of each index and utilize appropriately, since different indices have been developed for different purposes. It should be also noted that none of these widely used indices takes extent of inflammation into account. Currently, MES is most widely used in clinical trials for its simplicity, and UCEIS may become more common in the future because of its lower inter-observer variability. Definition of mucosal healing in each index has not been established yet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 1961;30:393–407.

    CAS  PubMed  Google Scholar 

  2. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J. 1964;1(5375):89–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuk E, Borgen L. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92(6):1894–8.

    Article  CAS  PubMed  Google Scholar 

  4. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625–9. doi:10.1056/NEJM198712243172603.

    Article  CAS  PubMed  Google Scholar 

  5. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298(6666):82–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Naganuma M, Ichikawa H, Inoue N, Kobayashi T, Okamoto S, Hisamatsu T, Kanai T, Ogata H, Iwao Y, Hibi T. Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients. J Gastroenterol. 2010;45(9):936–43. doi:10.1007/s00535-010-0244-2.

    Article  PubMed  Google Scholar 

  7. Kobayashi T, Naganuma M, Okamoto S, Hisamatsu T, Inoue N, Ichikawa H, Takayama T, Saito R, Sujino T, Ogata H, Iwao Y, Hibi T. Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine a treatment for ulcerative colitis. J Gastroenterol. 2010;45(11):1129–37. doi:10.1007/s00535-010-0273-x.

    Article  PubMed  Google Scholar 

  8. Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lemann M, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Bernhardt CA, Mary JY, Sandborn WJ. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the ulcerative colitis endoscopic index of severity (UCEIS). Gut. 2012;61(4):535–42. doi:10.1136/gutjnl-2011-300486.

    Article  PubMed  Google Scholar 

  9. Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, Feagan BG, Hanauer SB, Lichtenstein GR, Marteau PR, Reinisch W, Sands BE, Yacyshyn BR, Schnell P, Bernhardt CA, Mary JY, Sandborn WJ. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145(5):987–95. doi:10.1053/j.gastro.2013.07.024.

    Article  PubMed  Google Scholar 

  10. Thia KT, Loftus Jr EV, Pardi DS, Kane SV, Faubion WA, Tremaine WJ, Schroeder KW, Harmsen SW, Zinsmeister AR, Sandborn WJ. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis. 2011;17(6):1257–64. doi:10.1002/ibd.21480.

    Article  PubMed  Google Scholar 

  11. Samuel S, Bruining DH, Loftus Jr EV, Thia KT, Schroeder KW, Tremaine WJ, Faubion WA, Kane SV, Pardi DS, de Groen PC, Harmsen WS, Zinsmeister AR, Sandborn WJ. Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures. Clin Gastroenterol Hepatol. 2013;11(1):49–54. e41 doi:10.1016/j.cgh.2012.08.003.

    Article  PubMed  Google Scholar 

  12. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, Dupas JL, Savoye G, Balde M, Marti R, Lerebours E, Cortot A, Salomez JL, Turck D, Colombel JF. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 2009;104(8):2080–8. doi:10.1038/ajg.2009.177.

    Article  PubMed  Google Scholar 

  13. Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrugger RW. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104(2):371–83. doi:10.1038/ajg.2008.38.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Insitiute Hospital, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8642, Japan

    Taku Kobayashi

Authors
  1. Taku Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taku Kobayashi .

Editor information

Editors and Affiliations

  1. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Insitiute Hospital, Minato-ku, Tokyo, Japan

    Toshifumi Hibi

  2. The Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, Japan

    Tadakazu Hisamatsu

  3. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Insitiute Hospital, Minato-ku, Tokyo, Japan

    Taku Kobayashi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Japan

About this chapter

Cite this chapter

Kobayashi, T. (2018). Endoscopic Indices for Ulcerative Colitis. In: Hibi, T., Hisamatsu, T., Kobayashi, T. (eds) Advances in Endoscopy in Inflammatory Bowel Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56018-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56018-0_16

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56016-6

  • Online ISBN: 978-4-431-56018-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation